R-4 based DNA vaccine (Lipotek)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameR-4 based DNA vaccine (Lipotek)
Drug Alias Namedendritic cell-specific antigen targeting DNA vaccine (Lipotek)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipotek Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipotek Pty Ltd
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A